5月28日，波士顿科学盘中下跌3.28%，报48.805美元/股，成交额4.34亿美元，延续前一交易日跌势。
消息面上，公司CEO Mike Mahoney在行业会议上表示今年面临的挑战超出预期，叠加Leerink Partners将目标价从87美元大幅下调至74美元（维持跑赢大盘评级），进一步压制市场情绪。此前高盛已将目标价从84美元下调至81美元，FDA披露的起搏器软件升级召回事件亦持续发酵。当前股价较52周高点109.50美元已回落逾55%，基本面方面，公司一季度营收52.03亿美元，同比增长11.58%，归母净利润13.41亿美元，同比增长98.96%。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.